WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018080795) HYDROXYCITRIC ACID COMPOUNDS AND CAPSULE LIQUID DELIVERY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/080795 International Application No.: PCT/US2017/056111
Publication Date: 03.05.2018 International Filing Date: 11.10.2017
IPC:
A61J 3/00 (2006.01) ,A61J 3/07 (2006.01) ,A61K 9/08 (2006.01) ,A61K 31/00 (2006.01) ,A61K 47/10 (2017.01)
Applicants: GLYKON TECHNOLOGIES GROUP, LLC[US/US]; 24 Roy Street, #401 Seattle, Washington 98109-4018, US
Inventors: CLOUATRE, Dallas L.; US
CLOUATRE, Daniel E.; US
Agent: BOZICEVIC, Karl; US
Priority Data:
62/412,39325.10.2016US
Title (EN) HYDROXYCITRIC ACID COMPOUNDS AND CAPSULE LIQUID DELIVERY
(FR) COMPOSÉS D'ACIDE HYDROXYCITRIQUE ET ADMINISTRATION DE LIQUIDE EN CAPSULE
Abstract:
(EN) A capsule oral delivery system is disclosed. The system includes an outer capsule completely enclosing an inner content, or a hard shell comprised of hydroxypropyl methylcellulose (HPMC) enclosing the content. A liquid formulation forming the inner content of the outer capsule is comprised of a hydroxycitric acid (HCA) salt, water, and glycerol, with the HCA being completely dissolved in the water and glycerol which may be the only components present in the capsule, which may be administered to a patient in a method of treatment to cause weight loss when repeatedly administered.
(FR) L’invention concerne un système d’administration orale de type capsule. Le système comprend une capsule externe renfermant totalement un contenu interne, ou une coque dure constituée d'hydroxypropylméthylcellulose (HPMC) renfermant le contenu. Une formulation liquide formant le contenu interne de la capsule externe est constituée d'un sel d'acide hydroxycitrique (HCA), d'eau et de glycérol, le HCA totalement dissous dans l'eau et le glycérol pouvant être les seuls constituants présents dans la capsule, qui peut être administrée à un patient dans le cadre d’une méthode de traitement destinée à provoquer une perte de poids lorsqu'elle est administrée de manière répétée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)